Investigator
GSK
Elizabeth received her BS in biochemistry from SUNY Geneseo in 2016 and her PhD in Chemistry from the University of Delaware in 2021. Since 2021 she has worked in the encoded technologies group at GSK in Cambridge, MA on the development and utilization of new DNA encoded library based small molecule drug discovery methods.